Metabolomic fingerprinting in the comprehensive study of liver changes associated with onion supplementation in hypercholesterolemic Wistar rats

International Journal of Molecular Sciences

Volumn 18, Issue 2, 2017, Pages

  González Peña, Diana ^a   Dudzik, Danuta ^b   García, Antonia ^b   de Ancos, Begoña ^a   Barbas, Coral ^b   Sánchez Moreno, Concepción ^a  

^a INSTITUTE OF FOOD SCIENCE   (Spain)

^b UNIVERSIDAD SAN PABLO CEU   (Spain)

Author keywords

CE MS; Functional food; GC MS; Hypercholesterolemia; LC MS; Mass spectrometry; Metabolome; Non alcoholic fatty liver disease (NAFLD); Non targeted metabolomics

Indexed keywords

ACYLCARNITINE; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CARNITINE; CATALASE; CHOLESTEROL; GLUTATHIONE PEROXIDASE; PALMITOYLCARNITINE; SUPEROXIDE DISMUTASE; TRIACYLGLYCEROL LIPASE; TRIACYLGLYCEROL;

AMINO ACID SYNTHESIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CAPILLARY ELECTROPHORESIS; CHOLESTEROL DIET; CITRIC ACID CYCLE; CONTROLLED STUDY; FATTY ACID OXIDATION; FINGER DERMATOGLYPHICS; FOOD INTAKE; HEPATIC EXTRACTION RATIO; HEPATOMEGALY; HYPERCHOLESTEROLEMIA; LIPID METABOLISM; LIPID STORAGE; LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY; LIVER FUNCTION; LIVER METABOLISM; LIVER PROTECTION; MALE; MASS FRAGMENTOGRAPHY; METABOLOMICS; NONALCOHOLIC FATTY LIVER; NONHUMAN; ONION; QUALITY CONTROL; SAMPLING; TIME OF FLIGHT MASS SPECTROMETRY; ANIMAL; CHEMISTRY; DIETARY SUPPLEMENT; DISCRIMINANT ANALYSIS; LEAST SQUARE ANALYSIS; LIQUID CHROMATOGRAPHY; LIVER; METABOLISM; METABOLOME; PROCEDURES; WISTAR RAT;

ANIMALS; CHOLESTEROL; CHROMATOGRAPHY, LIQUID; DIETARY SUPPLEMENTS; DISCRIMINANT ANALYSIS; ELECTROPHORESIS, CAPILLARY; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HYPERCHOLESTEROLEMIA; LEAST-SQUARES ANALYSIS; LIVER; MALE; METABOLOME; METABOLOMICS; ONIONS; RATS, WISTAR; TRIGLYCERIDES;

EID: 85013814026     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms18020267     Document Type: Article

References (51)

1. Kim, E.J.; Kim, B.H.; Seo, H.S.; Lee, Y.J.; Kim, H.H.; Son, H.H.; Choi, M.H. Cholesterol-induced non-alcoholic fatty liver disease and atherosclerosis aggravated by systemic inflammation. PLoS ONE 2014, 9, e97841. [CrossRef] [PubMed]
2. Bertot, L.C.; Adams, L.A. The natural course of non-alcoholic fatty liver disease. Int. J. Mol. Sci. 2016, 17. [CrossRef]
3. Long, M.T.; Wang, N.; Larson, M.G.; Mitchell, G.F.; Palmisano, J.; Vasan, R.S.; Hoffmann, U.; Speliotes, E.K.; Vita, J.A.; Benjamin, E.J.; et al. Nonalcoholic fatty liver disease and vascular function: Cross-sectional analysis in the framingham heart study. Arteriorcler. Thromb. Vasc. Biol. 2015, 35, 1284–1291. [CrossRef] [PubMed]
4. De Wit, N.J.; Afman, L.A.; Mensink, M.; Muller, M. Phenotyping the effect of diet on non-alcoholic fatty liver disease. J. Hepatol. 2012, 57, 1370–1373. [CrossRef] [PubMed]
5. Salomone, F.; Godos, J.; Zelber-Sagi, S. Natural antioxidants for non-alcoholic fatty liver disease: Molecular targets and clinical perspectives. Liver Int. 2016, 36, 5–20. [CrossRef] [PubMed]
6. Suleria, H.A.R.; Butt, M.S.; Anjum, F.M.; Saeed, F.; Khalid, N. Onion: Nature protection against physiological threats. Crit. Rev. Food Sci. Nutr. 2015, 55, 50–66. [CrossRef] [PubMed]
7. Ali, M.; Thomson, M.; Afzal, M. Garlic and onions: Their effect on eicosanoid metabolism and its clinical relevance. Prostaglandins Leukot. Essent. Fat. Acids 2000, 62, 55–73. [CrossRef] [PubMed]
8. Ogunmodede, O.S.; Saalu, L.C.; Ogunlade, B.; Akunna, G.G.; Oyewopo, A.O. An evaluation of the hypoglycemic, antioxidant and hepatoprotective potentials of onion (Allium cepa L.) on alloxan-induced diabetic rabbits. Int. J. Pharm. 2012, 8, 21–29.
9. Obioha, U.E.; Suru, S.M.; Ola-Mudathir, K.F.; Faremi, T.Y. Hepatoprotective potentials of onion and garlic extracts on cadmium-induced oxidative damage in rats. Biol. Trace Elem. Res. 2009, 129, 143–156. [CrossRef] [PubMed]
10. Emamat, H.; Foroughi, F.; Eini-Zinab, H.; Taghizadeh, M.; Rismanchi, M.; Hekmatdoost, A. The effects of onion consumption on treatment of metabolic, histologic, and inflammatory features of nonalcoholic fatty liver disease. J. Diabetes Metab. Disord. 2016, 15. [CrossRef] [PubMed]
11. Roldan-Marin, E.; Sanchez-Moreno, C.; Lloria, R.; de Ancos, B.; Cano, M.P. Onion high-pressure processing: Flavonol content and antioxidant activity. LWT Food Sci. Technol. 2009, 42, 835–841. [CrossRef]
12. González-Peña, D.; Colina-Coca, C.; Char, C.D.; Cano, M.P.; de Ancos, B.; Sánchez-Moreno, C. Hyaluronidase inhibiting activity and radical scavenging potential of flavonols in processed onion. J. Agric. Food Chem. 2013, 61, 4862–4872. [CrossRef] [PubMed]
13. Holmes, E.; Wijeyesekera, A.; Taylor-Robinson, S.D.; Nicholson, J.K. The promise of metabolic phenotyping in gastroenterology and hepatology. Nat. Rev. Gastroenterol. Hepatol. 2015, 12, 458–471. [CrossRef] [PubMed]
14. Naz, S.; dos Santos, D.C.M.; Garcia, A.; Barbas, C. Analytical protocols based on LC-MS, GC-MS and CE-MS for nontargeted metabolomics of biological tissues. Bioanalysis 2014, 6, 1657–1677. [CrossRef] [PubMed]
15. Beyoglu, D.; Idle, J.R. The metabolomic window into hepatobiliary disease. J. Hepatol. 2013, 59, 842–858. [CrossRef] [PubMed]
16. Llorach, R.; Garcia-Aloy, M.; Tulipani, S.; Vazquez-Fresno, R.; Andres-Lacueva, C. Nutrimetabolomic strategies to develop new biomarkers of intake and health effects. J. Agric. Food Chem. 2012, 60, 8797–8808. [CrossRef] [PubMed]
17. González-Peña, D.; Angulo, J.; Vallejo, S.; Colina-Coca, C.; de Ancos, B.; Sánchez-Ferrer, C.F.; Peiró, C.; Sánchez-Moreno, C. High-cholesterol diet enriched with onion affects endothelium-dependent relaxation and NADPH oxidase activity in mesenteric microvessels from Wistar rats. Nutr. Metab. 2014, 11, 57. [CrossRef] [PubMed]
18. González-Peña, D.; Dudzik, D.; Colina-Coca, C.; de Ancos, B.; García, A.; Barbas, C.; Sánchez-Moreno, C. Evaluation of onion as a functional ingredient in the prevention of metabolic impairments associated to diet-induced hypercholesterolaemia using a multiplatform approach based on LC-MS, CE-MS and GC-MS. J. Funct. Foods 2015, 19 Pt. A, 363–375. [CrossRef]
19. González-Peña, D.; Checa, A.; de Ancos, B.; Wheelock, C.E.; Sánchez-Moreno, C. New insights into the effects of onion consumption on lipid mediators using a diet-induced model of hypercholesterolemia. Redox Biol. 2017, 11, 205–212. [CrossRef] [PubMed]
20. Gorden, D.L.; Ivanova, P.T.; Myers, D.S.; McIntyre, J.O.; VanSaun, M.N.; Wright, J.K.; Matrisian, L.M.; Brown, H.A. Increased diacylglycerols characterize hepatic lipid changes in progression of human nonalcoholic fatty liver disease; comparison to a murine model. PLoS ONE 2011, 6, e22775. [CrossRef] [PubMed]
21. Wang, Y.M.; Zhang, B.; Xue, Y.; Li, Z.J.; Wang, J.F.; Xue, C.H.; Yanagita, T. The mechanism of dietary cholesterol effects on lipids metabolism in rats. Lipids Health Dis. 2010, 9, 4. [CrossRef] [PubMed]
22. Watanabe, M.; Houten, S.M.; Wang, L.; Moschetta, A.; Mangelsdorf, D.J.; Heyman, R.A.; Moore, D.D.; Auwerx, J. Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1c. J. Clin. Investig. 2004, 113, 1408–1418. [CrossRef] [PubMed]
23. Chitraju, C.; Trotzmuller, M.; Hartler, J.; Wolinski, H.; Thallinger, G.G.; Lass, A.; Zechner, R.; Zimmermann, R.; Kofeler, H.C.; Spener, F. Lipidomic analysis of lipid droplets from murine hepatocytes reveals distinct signatures for nutritional stress. J. Lipid Res. 2012, 53, 2141–2152. [CrossRef] [PubMed]
24. González-Peña, D.; Dudzik, D.; Colina-Coca, C.; de Ancos, B.; Garcia, A.; Barbas, C.; Sánchez-Moreno, C. Multiplatform metabolomic fingerprinting as a tool for understanding hypercholesterolemia in Wistar rats. Eur. J. Nutr. 2016, 55, 997–1010. [CrossRef] [PubMed]
25. Wang, Y.; Botolin, D.; Xu, J.; Christian, B.; Mitchell, E.; Jayaprakasam, B.; Nair, M.G.; Peters, J.M.; Busik, J.V.; Olson, L.K.; et al. Regulation of hepatic fatty acid elongase and desaturase expression in diabetes and obesity. J. Lipid Res. 2006, 47, 2028–2041. [CrossRef] [PubMed]
26. Lee, J.H.; Kim, G.H. Evaluation of antioxidant and inhibitory activities for different subclasses flavonoids on enzymes for rheumatoid arthritis. J. Food Sci. 2010, 75, H212–H217. [CrossRef] [PubMed]
27. Ma, J.Q.; Li, Z.; Xie, W.R.; Liu, C.M.; Liu, S.S. Quercetin protects mouse liver against CCL4-induced inflammation by the TLR2/4 and MAPK/NF-κB pathway. Int. Immunopharmacol. 2015, 28, 531–539. [CrossRef] [PubMed]
28. Ro, J.Y.; Ryu, J.H.; Park, H.J.; Cho, H.J. Onion (Allium cepa L.) peel extract has anti-platelet effects in rat platelets. Springerplus 2015, 4. [CrossRef] [PubMed]
29. Jung, C.H.; Cho, I.; Ahn, J.; Jeon, T.I.; Ha, T.Y. Quercetin reduces high-fat diet-induced fat accumulation in the liver by regulating lipid metabolism genes. Phytother. Res. 2013, 27, 139–143. [CrossRef] [PubMed]
30. D-glucuronide through modulation of peroxisome proliferator-activated receptor-alpha/sterol regulatory element-binding protein-1c signaling. Hepatol. Res. 2016, 46, 225–238. [CrossRef] [PubMed]
31. Regulska-Ilow, B.; Ilow, R. The influence of quercetin on fatty-acid content in selected organs of rats on diets with fresh and oxidized fat. Adv. Clin. Exp. Med. 2008, 17, 15–26.
32. Pepin, E.; Guay, C.; Delghingaro-Augusto, V.; Joly, E.; Madiraju, S.R.; Prentki, M. Short-chain 3-hydroxyacyl-coa dehydrogenase is a negative regulator of insulin secretion in response to fuel and non-fuel stimuli in ins832/13 β-cells. J. Diabetes 2010, 2, 157–167. [CrossRef] [PubMed]
33. Patel, S.G.; Hsu, J.W.; Jahoor, F.; Coraza, I.; Bain, J.R.; Stevens, R.D.; Iyer, D.; Nalini, R.; Ozer, K.; Hampe, C.S.; et al. Pathogenesis of A−β+ ketosis-prone diabetes. Diabetes 2013, 62, 912–922. [CrossRef] [PubMed]
34. Mai, M.; Tönjes, A.; Kovacs, P.; Stumvoll, M.; Fiedler, G.M.; Leichtle, A.B. Serum levels of acylcarnitines are altered in prediabetic conditions. PLoS ONE 2013, 8, e82459. [CrossRef] [PubMed]
35. Holecek, M.; Sispera, L. Effects of arginine supplementation on amino acid profiles in blood and tissues in fed and overnight-fasted rats. Nutrients 2016, 8, 206. [CrossRef] [PubMed]
36. Corbin, K.D.; Zeisel, S.H. Choline metabolism provides novel insights into nonalcoholic fatty liver disease and its progression. Curr. Opin. Gastroenterol. 2012, 28, 159–165. [CrossRef] [PubMed]
37. Calderón-Santiago, M.; Priego-Capote, F.; Galache-Osuna, J.G.; Luque de Castro, M.D. Method based on GC-MS to study the influence of tricarboxylic acid cycle metabolites on cardiovascular risk factors. J. Pharm. Biomed. Anal. 2013, 74, 178–185. [CrossRef] [PubMed]
38. Mailloux, R.J.; Beriault, R.; Lemire, J.; Singh, R.; Chenier, D.R.; Hamel, R.D.; Appanna, V.D. The tricarboxylic acid cycle, an ancient metabolic network with a novel twist. PLoS ONE 2007, 2, e690. [CrossRef] [PubMed]
39. Johari, N.Z.; Ismail, I.S.; Sulaiman, M.R.; Abas, F.; Shaari, K. Acute toxicity and metabolomics analysis of hypocholesterolemic effect of Mentha piperita aqueous extract in Wistar rats. Int. J. Appl. Res. Nat. Prod. 2015, 8, 1–11.
40. ′ -O-β-glucoside by human volunteers after the consumption of onions. Free Radic. Res. 1998, 29, 257–269. [CrossRef] [PubMed]
41. De Vries, J.H.; Hollman, P.C.; Meyboom, S.; Buysman, M.N.; Zock, P.L.; van Staveren, W.A.; Katan, M.B. Plasma concentrations and urinary excretion of the antioxidant flavonols quercetin and kaempferol as biomarkers for dietary intake. Am. J. Clin. Nutr. 1998, 68, 60–65. [PubMed]
42. Noroozi, M.; Burns, J.; Crozier, A.; Kelly, I.E.; Lean, M.E. Prediction of dietary flavonol consumption from fasting plasma concentration or urinary excretion. Eur. J. Clin. Nutr. 2000, 54, 143–149. [CrossRef] [PubMed]
43. Shi, Y.; Williamson, G. Comparison of the urinary excretion of quercetin glycosides from red onion and aglycone from dietary supplements in healthy subjects: A randomized, single-blinded, cross-over study. Food Funct. 2015, 6, 1443–1448. [CrossRef] [PubMed]
44. Mullen, W.; Edwards, C.A.; Crozier, A. Absorption, excretion and metabolite profiling of methyl-, glucuronyl-, glucosyl- and sulpho-conjugates of quercetin in human plasma and urine after ingestion of onions. Br. J. Nutr. 2006, 96, 107–116. [CrossRef] [PubMed]
45. Park, J.; Kim, J.; Kim, M.K. Onion flesh and onion peel enhance antioxidant status in aged rats. J. Nutr. Sci. Vitaminol. 2007, 53, 21–29. [CrossRef] [PubMed]
46. Azuma, K.; Minami, Y.; Ippoushi, K.; Terao, J. Lowering effects of onion intake on oxidative stress biomarkers in streptozotocin-induced diabetic rats. J. Clin. Biochem. Nutr. 2007, 40, 131–140. [CrossRef] [PubMed]
47. Ige, S.F.; Akhigbe, R.E. Common onion (Allium cepa) extract reverses cadmium-induced organ toxicity and dyslipidaemia via redox alteration in rats. Pathophysiology 2013, 20, 269–274. [CrossRef] [PubMed]
48. Reeves, P.G. Components of the AIN-93 diets as improvements in the AIN-76A diet. J. Nutr. 1997, 127, 838s–841s. [PubMed]
49. Naz, S.; García, A.; Barbas, C. Multiplatform analytical methodology for metabolic fingerprinting of lung tissue. Anal. Chem. 2013, 85, 10941–10948. [CrossRef] [PubMed]
50. Xia, J.; Sinelnikov, I.V.; Han, B.; Wishart, D.S. MetaboAnalyst 3.0—Making metabolomics more meaningful. Nucleic Acids Res. 2015, 43, W251–W257. [CrossRef] [PubMed]
51. Westerhuis, J.A.; Hoefsloot, H.C.J.; Smit, S.; Vis, D.J.; Smilde, A.K.; Velzen, E.J.J.; Duijnhoven, J.P.M.; Dorsten, F.A. Assessment of PLSDA cross validation. Metabolomics 2008, 4, 81–89. [CrossRef]